EPTIS
BAM Logo

Clinical PT- Immunosuppressive Drugs

[EP Clínico- Drogas Imunossupressoras]

EPTIS factsheet 444442 | Last revision 2017-12-01 | URL: https://www.eptis.bam.de/pts444442 https://www.eptis.bam.de/pts444442

PT provider
PT provider ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda
Based in Brazil
Language(s) Portuguese/ English / Spanish
Remarks
Keywords
Product groups Health care / medical devices
Human test material
Laboratory / scientific equipment
Process control systems
Testing fields Biology
Medical analysis
Technical details
Test item Tested property Testing method
Lyophilised total blood Dexametasone Quantitative assay
Azathioprine Quantitative assay
Cyclosporine Quantitative assay
Everolimus Quantitative assay
Sirolimus (rapamicin) Quantitative assay
Tacrolimus Quantitative assay
Mycophenolic acid Quantitative assay
Aims of the PT scheme
Target group of participants No restrictions.
Linked to specific legislation / standards ABNT NRB ISO/IEC 17043:2011
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee Variable costs. For this information, please contact ControlLab.
Regularly operated Yes (4 rounds per year)
Year of first operation 2013
Contact details of the PT provider
Provider Contact person
ControlLab Controle de Qualidade para Laboratórios Ltda
Rua Ana Neri 416 Benfica
20911-442 Rio de Janeiro
Brazil

Phone: +55-21-3891 9900
Fax: +55-21-3891 9901
Web: http://www.controllab.com.br http://www.controllab.com.br
Vinicius Biasoli
Phone: +55-21-3891 9900
Fax: +55-21-3891 9901
Email: vinicius.biasoli@controllab.com.br vinicius.biasoli@controllab.com.br
If you find any mistakes please contact the responsible EPTIS coordinator in Brazil, Mr Paulo Roberto da Fonseca Santos. Mr Paulo Roberto da Fonseca Santos.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21